Sartorius (OTCMKTS:SARTF) Stock Price Up 2.3% – Still a Buy?

Sartorius (OTCMKTS:SARTF)’s stock price shot up 2.3% on Monday . The stock traded as high as $225.00 and last traded at $225.00. 4 shares traded hands during trading, an increase of 7,900% from the average session volume of 0 shares. The stock had previously closed at $220.00.

Sartorius Stock Up 2.3%

The company has a 50-day moving average of $212.49 and a 200 day moving average of $200.82. The company has a current ratio of 0.95, a quick ratio of 0.49 and a debt-to-equity ratio of 0.89.

Sartorius (OTCMKTS:SARTF) last released its earnings results on Thursday, October 16th. The company reported $1.26 EPS for the quarter, beating the consensus estimate of $1.25 by $0.01. The company had revenue of $987.65 million during the quarter, compared to analysts’ expectations of $972.82 million. Sartorius had a return on equity of 8.19% and a net margin of 3.82%.

About Sartorius

Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.

The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.